Power Up Your Morning with iBIO NewsBrief!
Get the daily email that keeps you informed and connected in the life sciences industry
📲 READ THE LATEST NEWSLETTER
iBIO IN THE NEWS
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
PRESS RELEASES AND BLOGS
MEMBER NEWS
POLICY NEWS
IBIO Adds Its Voice to Growing List of State Associations Providing Feedback to CMS on the Translational Coverage for Emerging Technologies Notice
Patients will lose access to 40% of future medicines because of the IRA, new research finds.
iBIO Signs Letter Urging Immediate Action on R&D Amortization
IBIO Statement on White House Budget Proposal
ALL NEWS
Chicago’s Pathos AI Raises $62M to Advance AI-Driven Drug Development
Pathos AI, a Chicago-based biotech startup, has secured $62 million in Series C funding to advance...
AbbVie to Acquire Alzheimer’s Drug Developer Aliada Therapeutics for $1.4 Billion
AbbVie announced today it will acquire Boston-based Aliada Therapeutics in a $1.4 billion cash...
FDA Approves Iterum’s Novel Oral Antibiotic for Urinary Tract Infections
Chicago-headquartered Iterum Therapeutics (Nasdaq: ITRM) has received U.S. Food and Drug...
iBIO Launches New STEM Kits for Local Chicago Students
Bristol Myers Squibb-sponsored kits will be distributed to 4th-8th graders at Frank W. Gunsaulus...
Chicago’s Quantum Leap: Pioneering the Future of Drug Discovery
In the heart of the Midwest, a technological revolution is brewing that could transform the...